NCT04239118

New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 112 (actual)
• Sponsor: Voronezh N.N. Burdenko State Medical Academy · Academic / Other
• Sex: All
• Age: 44 Years – 67 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study was to improve treatment results of patients with bleeding gastroduodenal ulcers by endoscopic applications of autoplasma, enriched with platelets and granular sorbent aseptisorb-A.

Detailed description

The clinical study was conducted on the basis of the Voronezh city specialized Center for the treatment of patients with gastrointestinal bleeding. The study included 112 patients with ulcerative gastroduodenal bleeding. All patients were divided into two groups by random sampling: the main group (n=57 people) and the comparison group (n=55 people). In the treatment of patients of the main group (57 people), an individual approach was used with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets, in the complex endoscopic treatment of bleeding-complicated gastroduodenal ulcers (Patent Russian Federation (RF) № 2632771). In the comparison group (55 people), traditional methods of endoscopic hemostasis were used.

Conditions

• Ulcer Hemorrhage

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Complex endoscopic treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets	Complex endoscopic bleeding ulcers treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets
PROCEDURE	Traditional methods of endoscopic hemostasis	Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents

Timeline

• Start date: 2018-01-10
• Primary completion: 2019-06-16
• Completion: 2019-12-20
• First posted: 2020-01-23
• Last updated: 2020-01-23

Locations

1 site across 1 country: Russia